Tyrosine Kinase Inhibitors: Motesanib

пятница, 19 ноября 2010 г.

Targets: Motesanib (AMG-706) is a multitargeted anticancer agent with an inhibitory action on VEGFR1-3, PDGFR,c-KIT.

(WO/2002/066470) SUBSTITUTED ALKYLAMINE DERIVATIVES AND METHODS OF USE